Cerebral and peripheral amyloid phagocytes--an old liaison with a new twist

Mathias Jucker1, Frank L Heppner

  • 1Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. mathias.jucker@uni-tuebingen.de

Neuron
|July 11, 2008
PubMed

Insights

Peripheral macrophages entering the brain may reduce Alzheimer's disease (AD) pathology by decreasing amyloid buildup. This finding adds complexity to the debate on whether these immune cells are helpful or harmful in AD.

Area of Science:

  • Neuroimmunology
  • Neurodegenerative Diseases
  • Alzheimer's Disease Pathogenesis

Background:

  • Alzheimer's disease (AD) is characterized by amyloid plaques in the brain.
  • The role of immune cells, specifically macrophages and microglia, in AD pathogenesis is debated.
  • Understanding the contribution of peripheral immune cells to brain pathology is crucial.

Purpose of the Study:

  • To investigate the role of peripheral macrophages in Alzheimer's disease.
  • To determine if peripheral macrophages influence cerebral amyloidosis.
  • To contribute to the ongoing discussion regarding the beneficial or detrimental effects of mononuclear cells in AD.

Main Methods:

  • The study by Town et al. in Nature Medicine examined the infiltration of peripheral macrophages into the brain.
  • Assessed the impact of these infiltrating cells on amyloid deposition.
  • Correlated macrophage presence with markers of Alzheimer's disease pathology.

Main Results:

  • Peripheral macrophages were observed to invade the brain.
  • Infiltration of peripheral macrophages was associated with a reduction in cerebral amyloidosis.
  • These findings suggest a potential protective role for peripheral macrophages in AD.

Conclusions:

  • Peripheral macrophages may play a significant role in mitigating Alzheimer's disease pathology.
  • The study intensifies the debate on the dual role of mononuclear cells (macrophages and microglia) in AD.
  • Further research is warranted to elucidate the precise mechanisms and therapeutic potential of peripheral macrophages in AD.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...